期刊文献+

肠外营养配以谷氨酰胺和重组人生长激素纠正肝、肾移植后的低蛋白血症 被引量:16

Parenteral nutrition, glutamine and growth horme ameliorate hypoproteinemia after liver and kidney transplantation
暂未订购
导出
摘要 目的 :研究谷氨酰胺 (Gln)和重组人生长激素 (rhGH)治疗肝、肾移植后低蛋白血症的效果。 方法 :术后不同时期内发生低蛋白血症的 10例肝移植和 12例肾移植病人 ,每天接受含有 10 0ml丙氨酰 谷氨酰胺 (Ala Gln)二肽的肠外营养支持 (PN) ,连续 12~ 17天 ;每天给予rhGH 4U皮下注射 ,连续 12~ 17天。治疗前和治疗后的第 7、14和2 1天 ,分别检测血中白蛋白 (Alb)、总蛋白 (TP)的变化。 结果 :2 2例病人接受PN +Gln +rhGH治疗后的第 7、14和2 1天 ,血清Alb和TP均有不同程度的升高 ,其中第 14和 2 1天检测的Alb和TP水平与术前比差异显著。另有 2例并发肠瘘的病人由于低蛋白血症的纠正而自行愈合。 结论 :PN配以Gln和rhGH可有效地纠正肝、肾移植后的低蛋白血症。 Objectives: To investigate the effect of parenteral nutrition(PN), glutamine (Gln) and growth hormone in ametiorating hypoproteinemia after liver and kidney transptantation. Methods: Ten liver transplantation recipients and 12 kidney transplantation recipients with hypoproteinemia received parenteral nutrition supplemented with alanyl glutamine dipeptide (Ala Gln, 100 ml/d) and recombined human GH(rhGH, 4 U/d) for 12~17 days. Serum albumin (Alb) and total protein (TP) were determined respectively before and days 7,14 and 21 after therapy. Results:On the days 7 and 14 after therapy,the serum levels of Alb and TP were elevated. Statistic analysis showed that Alb and TP on the days 14 and 21 had a significant increase when compared with that before therapy( P < 0.05 ). Another 2 patients with intestinal fistula due to their hypoproteinemia cured with no operation. Conclusions: PN Combined with Gln and rhGH could ameliorate hypoproteinenia after liver and kidney transplantation.
出处 《肠外与肠内营养》 CAS 2003年第2期103-105,共3页 Parenteral & Enteral Nutrition
关键词 肝、肾移植 低蛋白血症 谷氨酰胺 生长激素 Liver,kidney transplantation Hypoproteinemia Glutamine Growth hormone
  • 相关文献

参考文献5

  • 1[1]Falduto MT, Young AP, Hickson RC. Exercise inhibits glucocorticoid-induced glutamine synthetase expression in red skeletal muscles [J]. Am J physiol, 1997, 262(cell physiol 31):214-220.
  • 2PeterFuerstMD.谷氨酰胺双肽在临床营养中的运用[J].中国临床营养杂志,2001,9(2):88-88. 被引量:2
  • 3[3]Fine RN, Sullivan EK, Kuntze J, et al. The impact of recombinant human growth hormone treatment renal insufficiency on renal transplant recipients[J]. J Pediatr, 2000, 136(3):376-382.
  • 4[4]Lebl J, Sediva A, Frisch H, et al. Lymphocyte subsets in renal transplant recipients during growth hormone therapy[J]. Endocr Regul, 1999, 33(1):3-8.
  • 5[5]Zivicnjak M, Franke D, Ehrich JH, et al. Does growth hormone therapy harmonize distorted morphology composition in chronic renal failure?[J] Pediatr Nephrol, 2000, 15(3-4):229-235.

共引文献1

同被引文献101

引证文献16

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部